Rising demand for cold and flu medication gave Adcock Ingram’s annual performance a boost. The pharmaceutical manufacturer says over-the-counter turnover jumped 7.9%, and this supported a 6% rise in overall turnover. Business Day TV spoke to CEO Andy Hall for more details.
WATCH: Increased demand for flu, cold medication work in Adcock’s favour
Business Day TV speaks to Adcock Ingram CEO Andy Hall
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.